(Q46402216)

English

Downregulation but lack of promoter hypermethylation or somatic mutations of the potential tumor suppressor CXXC5 in MDS and AML with deletion 5q.

scientific article published on 20 January 2013

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/23190153

Downregulation but lack of promoter hypermethylation or somatic mutations of the potential tumor suppressor CXXC5 in MDS and AML with deletion 5q. (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/23190153

hypermethylation

1 reference

based on heuristic

inferred from title

author name string

Marianne B Treppendahl

1

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/23190153

Lars Möllgård

2

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/23190153

Eva Hellström-Lindberg

3

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/23190153

Paul Cloos

4

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/23190153

Kirsten Grønbaek

5

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/23190153

publication date

20 January 2013

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/23190153

European Journal of Haematology

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/23190153

90

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/23190153

3

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/23190153

259-260

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/23190153

The role of mutations in epigenetic regulators in myeloid malignancies

1 reference

https://api.crossref.org/works/10.1111%2FEJH.12045

21 January 2018

Functional involvement of RINF, retinoid-inducible nuclear factor (CXXC5), in normal and tumoral human myelopoiesis

1 reference

https://api.crossref.org/works/10.1111%2FEJH.12045

21 January 2018

CXXC domain of human DNMT1 is essential for enzymatic activity

1 reference

https://api.crossref.org/works/10.1111%2FEJH.12045

21 January 2018

The MT domain of the proto-oncoprotein MLL binds to CpG-containing DNA and discriminates against methylation

1 reference

https://api.crossref.org/works/10.1111%2FEJH.12045

21 January 2018

Mbd1 is recruited to both methylated and nonmethylated CpGs via distinct DNA binding domains

1 reference

https://api.crossref.org/works/10.1111%2FEJH.12045

21 January 2018

Identification and characterization of the DNA binding domain of CpG-binding protein

1 reference

https://api.crossref.org/works/10.1111%2FEJH.12045

21 January 2018

Genome-wide regulation of 5hmC, 5mC, and gene expression by Tet1 hydroxylase in mouse embryonic stem cells

1 reference

https://api.crossref.org/works/10.1111%2FEJH.12045

21 January 2018

CXXC5 is a novel BMP4-regulated modulator of Wnt signaling in neural stem cells

1 reference

https://api.crossref.org/works/10.1111%2FEJH.12045

21 January 2018

A novel Wilms tumor 1 (WT1) target gene negatively regulates the WNT signaling pathway

1 reference

https://api.crossref.org/works/10.1111%2FEJH.12045

21 January 2018

The Wnt/beta-catenin pathway is required for the development of leukemia stem cells in AML.

1 reference

https://api.crossref.org/works/10.1111%2FEJH.12045

21 January 2018

Chromosome 5q deletion and epigenetic suppression of the gene encoding alpha-catenin (CTNNA1) in myeloid cell transformation

1 reference

https://api.crossref.org/works/10.1111%2FEJH.12045

21 January 2018

Identification of RPS14 as a 5q- syndrome gene by RNA interference screen

1 reference

https://api.crossref.org/works/10.1111%2FEJH.12045

21 January 2018

Identification of miR-145 and miR-146a as mediators of the 5q- syndrome phenotype

1 reference

https://api.crossref.org/works/10.1111%2FEJH.12045

21 January 2018

Lenalidomide inhibits the malignant clone and up-regulates the SPARC gene mapping to the commonly deleted region in 5q- syndrome patients

1 reference

https://api.crossref.org/works/10.1111%2FEJH.12045

21 January 2018

Haploinsufficiency of Apc leads to ineffective hematopoiesis

1 reference

https://api.crossref.org/works/10.1111%2FEJH.12045

21 January 2018

Haploinsufficiency of EGR1, a candidate gene in the del(5q), leads to the development of myeloid disorders

1 reference

https://api.crossref.org/works/10.1111%2FEJH.12045

21 January 2018

Identifiers

10.1111/EJH.12045

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/23190153

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/23190153

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46402216&oldid=1423578289"